Rapid Dose Therapeutics Corp
CNSX:DOSE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.13
0.24
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
R
|
Rapid Dose Therapeutics Corp
CNSX:DOSE
|
19.3m CAD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57B USD |
Loading...
|
|
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
28.2B USD |
Loading...
|
|
| JP |
|
Terumo Corp
TSE:4543
|
3.2T JPY |
Loading...
|
|
| US |
|
Insulet Corp
NASDAQ:PODD
|
18.8B USD |
Loading...
|
|
| US |
A
|
ABIOMED Inc
LSE:0H7S
|
17.2B USD |
Loading...
|
|
| US |
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
17.1B USD |
Loading...
|
|
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
17.3B USD |
Loading...
|
|
| US |
|
Penumbra Inc
NYSE:PEN
|
14.1B USD |
Loading...
|
|
| NZ |
|
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
|
22.7B NZD |
Loading...
|
|
| US |
|
Shockwave Medical Inc
F:36M
|
11.3B EUR |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Rapid Dose Therapeutics Corp
Glance View
Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The firm provides drug-delivery technologies. The firm also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries. The company owns an oral fast-dissolving drug delivery system, QuickStrip, which is capable of releasing into the blood stream a list of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver. Its QuickStrip Energy product delivers energizing caffeine. Its QuickStrip B12 product delivers vitamin B12 to user's system, assisting with metabolism and physical energy. Melatonin is its QuickStrip Sleep product that delivers melatonin to the user's system. The RDMx mixture is its formulation, which is processed using RDT production equipment.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Rapid Dose Therapeutics Corp is -175%, which is above its 3-year median of -344.3%.
Over the last 3 years, Rapid Dose Therapeutics Corp’s Net Margin has increased from -415.6% to -175%. During this period, it reached a low of -520.2% on May 31, 2024 and a high of -175% on Oct 1, 2025.